The ISH Council would like to acknowledge the assistance of the following Corporate Members who are participating in the ISH and therefore helping to promote the advancement of scientific research and knowledge in hypertension and associated cardiovascular diseases.
Current Corporate Members
By looking beyond the technology, our real commitment lies in building healthy lives. We aim to provide a total healthcare management service, aimed at preventing and improving such increasingly common health problems as hypertension, respiratory problems, diabetes and obesity.
Otsuka Medical Devices, the holding company for Otsuka’s medical device operations, focuses on ‘minimally invasive’ and ‘innovative’ therapeutic devices. These include ultrasound-based renal denervation, drug-device combinations, and novel solution devices targeted at drug-refractory patients and intractable diseases.
As one of its subsidiaries, ReCor Medical, headquartered in Palo Alto, CA, is focused on transforming the management of hypertension, the leading cardiovascular risk factor on the planet. ReCor has pioneered the innovative, minimally invasive use of ultrasound in renal denervation to lower blood pressure in patients with hypertension. The company is focused on investing in high quality product development efforts, as well as rigorous clinical studies to create a strong foundation for future clinical adoption.
For more information about Otsuka Medical Devices, visit: http://www.omd.otsuka.com/en/ For information about ReCor* and/or renal denervation, visit: https://www.recormedical.com/ *ReCor Medical, Inc. is a wholly owned subsidiary of Otsuka Medical Devices